Clinical Features and Burden Scores in Japanese Pediatric Migraines With Brainstem Aura, Hemiplegic Migraine, and Retinal Migraine.


Journal

Journal of child neurology
ISSN: 1708-8283
Titre abrégé: J Child Neurol
Pays: United States
ID NLM: 8606714

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 2 6 2020
medline: 26 10 2021
entrez: 2 6 2020
Statut: ppublish

Résumé

Migraines are a broad spectrum of disorders classified by the type of aura with some requiring attentive treatment. Vasoconstrictors, including triptans, should be avoided in the acute phase of migraines with brainstem aura, in hemiplegic migraine, and in retinal migraine. This study investigated the characteristics and burden of these migraines. Medical charts of 278 Japanese pediatric patients with migraines were retrospectively reviewed. Migraine burden of migraines with brainstem aura, hemiplegic migraines, and retinal migraine was assessed using the Headache Impact Test-6™ (HIT-6) and the Pediatric Migraine Disability Assessment scale (PedMIDAS). Of 278 patients screened, 12 (4.3%) patients with migraines with brainstem aura (n = 5), hemiplegic migraines (n = 2), and retinal migraine (n = 5) were enrolled in the study. All patients had migraine with/without typical aura, whereas some patients had coexisting migraine with another type of headache (chronic tension-type headache in 3 patients, and 1 each with frequent episodic tension-type headache, headache owing to medication overuse, and chronic migraine). Migraines with brainstem aura, hemiplegic migraines, and retinal migraine patients with coexisting headaches had higher HIT-6 or PedMIDAS scores, whereas migraines with brainstem aura, hemiplegic migraines, and retinal migraine patients without coexisting headache did not show high HIT-6 or PedMIDAS scores. All migraines with brainstem aura, hemiplegic migraines, and retinal migraine patients experienced migraine with or without typical aura, and some patients having other coexisting headaches also had high PedMIDAS and HIT-6 scores. PedMIDAS and HIT-6 should not be considered diagnostic indicators of migraines with brainstem aura, hemiplegic migraines, or retinal migraine. In clinical practice for headaches in children, careful history taking and proactive assessment of the aura are needed for accurate diagnosis of migraines with brainstem aura, hemiplegic migraines, and retinal migraine.

Sections du résumé

BACKGROUND
Migraines are a broad spectrum of disorders classified by the type of aura with some requiring attentive treatment. Vasoconstrictors, including triptans, should be avoided in the acute phase of migraines with brainstem aura, in hemiplegic migraine, and in retinal migraine. This study investigated the characteristics and burden of these migraines.
METHODS
Medical charts of 278 Japanese pediatric patients with migraines were retrospectively reviewed. Migraine burden of migraines with brainstem aura, hemiplegic migraines, and retinal migraine was assessed using the Headache Impact Test-6™ (HIT-6) and the Pediatric Migraine Disability Assessment scale (PedMIDAS).
RESULTS
Of 278 patients screened, 12 (4.3%) patients with migraines with brainstem aura (n = 5), hemiplegic migraines (n = 2), and retinal migraine (n = 5) were enrolled in the study. All patients had migraine with/without typical aura, whereas some patients had coexisting migraine with another type of headache (chronic tension-type headache in 3 patients, and 1 each with frequent episodic tension-type headache, headache owing to medication overuse, and chronic migraine). Migraines with brainstem aura, hemiplegic migraines, and retinal migraine patients with coexisting headaches had higher HIT-6 or PedMIDAS scores, whereas migraines with brainstem aura, hemiplegic migraines, and retinal migraine patients without coexisting headache did not show high HIT-6 or PedMIDAS scores.
CONCLUSION
All migraines with brainstem aura, hemiplegic migraines, and retinal migraine patients experienced migraine with or without typical aura, and some patients having other coexisting headaches also had high PedMIDAS and HIT-6 scores. PedMIDAS and HIT-6 should not be considered diagnostic indicators of migraines with brainstem aura, hemiplegic migraines, or retinal migraine. In clinical practice for headaches in children, careful history taking and proactive assessment of the aura are needed for accurate diagnosis of migraines with brainstem aura, hemiplegic migraines, and retinal migraine.

Identifiants

pubmed: 32476572
doi: 10.1177/0883073820927840
doi:

Substances chimiques

Domperidone 5587267Z69
Imipramine OGG85SX4E4
Riboflavin TLM2976OFR
Ibuprofen WK2XYI10QM

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

667-673

Auteurs

Gaku Yamanaka (G)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Soken Go (S)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Shinichiro Morichi (S)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Mika Takeshita (M)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Natsumi Morishita (N)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Shinji Suzuki (S)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Takamatsu Tomoko (T)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Akiko Kasuga (A)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Atsuro Daida (A)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Yu Ishida (Y)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Shingo Oana (S)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Yusuke Suganami (Y)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Ryuhei Nagao (R)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Yasuyo Kashiwagi (Y)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Hisashi Kawashima (H)

Department of Pediatrics and Adolescent Medicine, Tokyo Medical University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH